menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-6 of 6  
 
1.  
Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. 2004 Dec 3 (revised 2013 Nov 6). NGC:010078
American Academy of Pediatrics - Medical Specialty Society; Centers for Disease Control and Prevention - Federal Government Agency [U.S.]; Department of Health and Human Services (U.S.) - Federal Government Agency [U.S.]; HIV Medicine Association - Disease Specific Society; Infectious Diseases Society of America - Medical Specialty Society; National Institutes of Health (U.S.) - Federal Government Agency [U.S.]; Pediatric Infectious Diseases Society - Medical Specialty Society. View all guidelines by the developer(s)
2.  
Special populations. In: Sexually transmitted diseases treatment guidelines, 2010. 1993 (revised 2010 Dec 17). NGC:008228
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
3.  
Premature rupture of membranes. 1998 Jun (revised 2013 Oct). NGC:010023
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s)
4.  
Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2004 Dec 17 (revised 2013 Jul 8). NGC:009837
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]; HIV Medicine Association - Disease Specific Society; Infectious Diseases Society of America - Medical Specialty Society; National Institutes of Health (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
5.  
Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. 2000 Feb (revised 2012 Jan). NGC:009107
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
6.  
British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. 2004 Dec (revised 2011 Oct). NGC:009170
British Association of Dermatologists - Medical Specialty Society. View all guidelines by the developer(s)
1-6 of 6